Johnson, the former Los Angeles Lakers star, is urging older adults to talk to their pharmacist or doctor about RSV vaccination through the “Sideline RSV” campaign.
Talk to your doctor or pharmacist about Arexvy today,” says the one-minute ad, touting its position as the first FDA-approved shot to protect against the virus. The ad is broadcast on all major network stations and online during shows such as “Today,” “Good Morning America,” “The Big Bang Theory” and “Nightly News.” GSK launched a television campaign to promote its vaccine for older adults. That is something that we’re going to continue to make very clear to Americans across the country.” “And RSV immunization for people over 60 and for infants. “We’re going to encourage Americans to get their updated COVID-19 vaccine, in addition to their annual flu shot,” White House press secretary Karine Jean-Pierre said on Aug.
It is the first RSV vaccine for maternal use and will draw more attention to the new shots. Regulators said last month that Pfizer’s version could be given to pregnant women so they confer immunity to their babies in the first six months after birth. Agency spokeswoman Kathleen Conley said doctors and patients should consider whether the patient has any chronic medical conditions or other risk factors that increase their risk of severe RSV disease, possible side effects such as fever or soreness at the injection site, and “the patient’s preference around getting the shot.” The vaccines were granted priority review status, which directs regulatory attention to drugs and vaccines that would be “significant improvements” over existing pharmaceuticals or treatments. Pfizer’s version has the brand name ABRYSVO.
GSK pointed to federal data showing that RSV causes about 177,000 hospitalizations and an estimated 14,000 deaths of U.S. The company estimates that the RSV vaccine would benefit nearly 56 million American seniors. In May, the Food and Drug Administration approved the GSK vaccine, which has the brand name Arexvy. “I think that’s why it’s so important to educate the providers, really talking to patients about the importance of getting all three vaccines.” “We anticipate a harder effort to get people to come get vaccinated,” said Claire Hannan, executive director of the Association of Immunization Managers. Interest in the COVID-19 shots lagged over time, and the pandemic and associated mandates fueled an era of vaccine hesitancy in activist circles and corners of the internet. It exceeded 70% of seniors as of March, according to the Centers for Disease Control and Prevention.Īdding a third shot will be a key test of seniors’ willingness to roll up their sleeves this fall. Flu shot coverage is trending in a better direction.
#Cdc vaccine passport series#
More than 9 in 10 American seniors got a two-dose primary series for COVID-19, but roughly 43% of them bothered to get an updated booster last fall, according to federal data. Tan said “most adult patients are unlikely to accept three vaccines at the same time, and so having the patient come back may be necessary.” He said public interest is hard to gauge, though the rough season last year put RSV on people’s radar.Īll three shots can be administered at once, though Dr. Providers who are aware of the burden of disease from RSV are delighted to have these new vaccines for their 60-and-older patients,” said Litjen Tan, chief policy and partnerships officer at, which promotes vaccination through educational materials for the public and health professionals. “The large amount of disease we had last year definitely spiked some interest. Drugmakers and immunization managers are spreading the word among senior homes and doctors serving older patients.
0 kommentar(er)
